fingolimod hydrochloride and Fatigue
fingolimod hydrochloride has been researched along with Fatigue in 4 studies
Research
Studies (4)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (50.00) | 24.3611 |
2020's | 2 (50.00) | 2.80 |
Authors
Authors | Studies |
---|---|
Al-Iedani, O; Lea, R; Lechner-Scott, J; Ramadan, S; Ribbons, K | 1 |
Bryll, A; Drabik, L; Karcz, P; Kolasinska, J; Kolasinska, M; Marona, M; Popiela, T; Skladzien, J; Slowik, A; Szaleniec, J; Wnuk, M; Ziekiewicz, M | 1 |
Debs, R; Delvaux, V; Lubetzki, C; Maillart, E; Masingue, M; Papeix, C; Vidal, JS | 1 |
Appel, S; Atassi, N; Berry, JD; Gill, A; Goyal, N; Grasso, DL; Macklin, EA; Mateen, F; Mejia, NI; Paganoni, S; Perrin, S; Rivner, M; Simpson, E; Tassinari, V; Vieira, F | 1 |
Trials
1 trial(s) available for fingolimod hydrochloride and Fatigue
Article | Year |
---|---|
Phase IIa trial of fingolimod for amyotrophic lateral sclerosis demonstrates acceptable acute safety and tolerability.
Topics: Adult; Aged; Amyotrophic Lateral Sclerosis; Bradycardia; Fatigue; Female; Fingolimod Hydrochloride; Humans; Immunosuppressive Agents; Male; Middle Aged; Single-Blind Method | 2017 |
Other Studies
3 other study(ies) available for fingolimod hydrochloride and Fatigue
Article | Year |
---|---|
Neurometabolic changes in multiple sclerosis: Fingolimod versus beta interferon or glatiramer acetate therapy.
Topics: Fatigue; Fingolimod Hydrochloride; Glatiramer Acetate; Humans; Immunosuppressive Agents; Interferon-beta; Multiple Sclerosis; Multiple Sclerosis, Relapsing-Remitting | 2022 |
Olfactory Dysfunction in Patients With Relapsing-Remitting Multiple Sclerosis Treated With Disease-Modifying Therapies.
Topics: Anosmia; Dimethyl Fumarate; Fatigue; Fingolimod Hydrochloride; Humans; Multiple Sclerosis; Multiple Sclerosis, Relapsing-Remitting; Recurrence | 2022 |
Fatigue evaluation in fingolimod treated patients: An observational study.
Topics: Adult; Fatigue; Female; Fingolimod Hydrochloride; Humans; Immunosuppressive Agents; Male; Multiple Sclerosis, Relapsing-Remitting; Prospective Studies; Treatment Outcome; Young Adult | 2017 |